Novartis16d
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
Benzinga.com17d
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as ...
Greek City Times18d
Novartis Scandal: Former Protected Witnesses Face Criminal Prosecution
Greece on Monday prosecuted a pair of protected witnesses for alleged perjury in a long-running bribery probe involving the Swiss pharmaceutical firm Novartis, a justice source said. The man and woman ...
FiercePharma22d
Novartis wins 11th-hour bid to block generic version of blockbuster heart med Entresto
The roller-coaster ride for Novartis—as it uses every bit of its legal muscle to extend Entresto's market exclusivity—took another zig on Thursday with a federal appellate court blocking the ...
BioSpace22d
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug Entresto. Novartis on Thursday secured a last-minute win against MSN ...
ENDPOINTS NEWS22d
No­var­tis en­ters fight against HHS for deny­ing its 340B re­bate mod­el
No­var­tis is the lat­est drug­mak­er to sue the gov­ern­ment for al­leged­ly re­ject­ing its pro­posed mod­el to dis­trib­ute fed­er­al drug dis­counts.
news.bloomberglaw22d
Novartis Sues HHS Over Cash Rebate Model in Drug Discount Plan
Novartis AG is challenging a federal health agency’s decision to rejects its proposal to discount drugs as a rebate rather than up-front to health providers that treat lower-income and uninsured ...
Yahoo Finance23d
Novartis wins temporary pause to Entresto generic launch in US
WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' blockbuster heart-failure drug Entresto late on Wednesday.
Reuters23d
Novartis wins temporary pause to Entresto generic launch in US
WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...
Reuters23d
US appeals court reinstates pause on generic version of Novartis' Entresto
WASHINGTON, Jan 16 - Novartis (NOVN.S), opens new tab won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic ...
Daily23d
Novartis Entresto US patent upheld by US Court of Appeals
Basel: Novartis has announced that the Company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the ...